Igniting growth and global leadership through innovation in MedTech devices, digital, and AI.
For leadership teams, investors, and governments.
Profile
More than two decades leading innovation, technology, R&D, and digital organizations across $500M to $5B+ MedTech businesses at GE HealthCare, BD, Carl Zeiss Meditec, and Welch Allyn, following a career in enterprise technology and aerospace at Peak Technologies, Sun Microsystems, McDonnell Douglas, and the U.S. Air Force.Today I advise MedTech leadership teams and investors on getting growth moving again. I also serve on the MedTech International Advisory Panel at A*STAR, Singapore's lead public sector R&D agency.
Jeffrey Schmidt
MedTech Advisor
Innovation · Digital · AI
Selected results
200+
Devices, software, cloud & AI solutions launched
2–3x
Market growth at flat or reduced R&D investment
$10M–$100M+
Built and led digital and AI MedTech businesses
>50%
Reduction in product development cycle time
100%
On time across 20+ R&D and 100+ sustaining projects
When we should talk
Portfolio and growth
Growth has flattened and the explanations keep changingToo many programs, and none of them funded to winThe R&D business cases are consistently missing their targets
Execution and speed
Development runs in years while your market moves in quartersR&D and sustaining spend keeps climbing but output doesn't followLaunch dates slip and the commercial team stops believing
Digital and AI
Your digital business is on the roadmap but not in the revenue planAI pilots keep kicking off and none of them reach commercial releaseDigital is pulling attention from the core instead of pulling it through
Organization and ecosystems
A team, site, or acquisition isn't aligned with the strategy or cultureYour technology organization has lost its edge or never had itGrowth depends on co-innovation or on ecosystems you don't have
What I've done about it
Portfolio and growth
Gained share in 13 of 16 quarters, growing at 3x the marketConsolidated 60 R&D projects into 9 programs at one company, and cut 300+ to under 130 at anotherPulled 7 launches forward by 1 to 8 quarters with no added fundingClosed $100M+ gaps in revenue plans through front-end innovation and co-innovation partnerships
Execution and speed
Cut device cycles from 4+ years to under 20 months at 4 companiesCut AI and app cycles from 18+ months to 6 months at 3 companiesTripled launches at flat R&D investment, cutting R&D intensity from 19% to 9%Raised on-time delivery from 0–40% to 100% at 4 companies, across 30+ concept, 20+ R&D, and 100+ sustaining projects a year
Digital and AI
Built and led digital and AI businesses at 5 companies, the largest $100M+Built a KOL-managed cloud AI research platform from zero to an eight-figure business with 220 paying institutionsPulled through eight-figure device, consumable, and service revenue with multi-year digitally-enabled subscriptions
Organization and ecosystems
Integrated 20+ acquisitions into single organizations, sites, platforms, and quality systemsHeld turnover at 4% in a Bay Area market running 8%Regained innovation leadership: 3 industry firsts, 30x scientific output, and 5 of 15 company innovation awards, up from noneGrew regional revenue 3x while cutting local R&D spend 40%+ and securing government grants
Posts and articles
A running series on how a stalled MedTech business gets back to growth: portfolio, execution, platforms, and co-innovation.
.
A running series on what is changing in MedTech AI, and what it means for regulated products with five-year lifecycles.
Summit Park Advisory LLC · Park City, Utah · [email protected]